InvestorsHub Logo

JWC3

11/17/21 2:15 PM

#336341 RE: TempePhil #336339

I agree TPhil.

tredenwater2

11/17/21 2:37 PM

#336342 RE: TempePhil #336339

Thanks Temp, makes sense. One thing is for sure, with the release of very good data from the PDD at a CTAD conference (and the risk of a major lawsuit on bad news) I doubt Dr M is holding back data due to average or subpar data from both RS and PDD. In light of this your opinion is as solid as any other out there!

Cheers

boi568

11/17/21 2:45 PM

#336343 RE: TempePhil #336339

Interesting post, Phil, thanks for your thoughts. I appreciate analyses that take into account things that haven't happened as well as things that have.

As for Parkinson's, it would not require much to extend your reasoning to suggest the possibility of a PD/PDD/Fragile x/Other basket trial based on a common MOA and biomarker.

nidan7500

11/17/21 4:40 PM

#336356 RE: TempePhil #336339

Tempephil, great post, very much appreciate your knowledge and insights.

Below are/were the expectations for the second half of this year:

oldandintheway

11/17/21 5:07 PM

#336359 RE: TempePhil #336339

As Dylan once noted - 'the hour is getting late...'